Acura Pharmaceuticals, Inc. Stock
Stocks
ACUR
US00509L8028
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | 0.00% |
|
-50.00% | -80.00% |
| 06-23 | Acura Pharmaceuticals, Inc. announced that it has received $0.2 million in funding | CI |
| 05-28 | Acura Pharmaceuticals, Inc. announced that it has received $0.1 million in funding | CI |
| Market Cap | 3.28M 2.87M 2.64M 2.44M 4.59M 316M 4.7M 31.6M 12.43M 155M 12.31M 12.04M 532M | P/E 2020 |
-5.25x | P/E 2021 | -25x |
|---|---|---|---|---|---|
| Enterprise Value | 3.41M 2.98M 2.75M 2.54M 4.78M 329M 4.89M 32.9M 12.94M 161M 12.82M 12.54M 554M | EV / Sales 2020 |
2.91x | EV / Sales 2021 | 20.9x |
| Free-Float |
98.31% | Yield 2020 * |
-
| Yield 2021 | - |
| 1 week | -50.00% | ||
| Current month | -88.89% | ||
| 1 month | -75.00% | ||
| 6 months | -80.00% | ||
| Current year | -80.00% |
| 1 week | 0 |  | 0 |
| 1 month | 0 | | 0 |
| Current year | 0 | | 0.01 |
| 1 year | 0 | | 0.01 |
| 3 years | 0 | | 0.75 |
| 5 years | 0 | | 0.75 |
| 10 years | 0 | | 2.09 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Jones
CEO | Chief Executive Officer | 67 | 2011-03-31 |
Bob Seiser
DFI | Director of Finance/CFO | 62 | 2024-07-31 |
Albert Brzeczko
CTO | Chief Tech/Sci/R&D Officer | 69 | 2009-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
William Skelly
CHM | Chairman | 75 | 1996-09-30 |
| Director/Board Member | 55 | 2002-11-30 | |
Bruce Wesson
BRD | Director/Board Member | 83 | 1998-02-28 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/2/26 | Fiscal year | Director | 150,000 | 0.2273% | ||
| 1/2/26 | Fiscal year | Director | 150,000 | 0.2273% | ||
| 1/2/26 | Fiscal year | Director | 150,000 | 0.2273% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -50.00% | -50.00% | -66.67% | 6.66K | |
| +0.40% | -0.61% | +56.31% | +57.69% | 53.83B | |
| -7.17% | -4.39% | +42.72% | +73.70% | 52.1B | |
| -0.21% | +0.04% | +6.23% | +412.85% | 23.48B | |
| -0.30% | +1.63% | -15.95% | -15.02% | 23.13B | |
| +3.46% | +2.52% | +36.64% | -5.41% | 19.36B | |
| -0.76% | -1.89% | +34.21% | -32.56% | 17.56B | |
| -5.16% | -7.00% | +168.44% | +291.24% | 15.2B | |
| +3.62% | 0.00% | +33.47% | +643.91% | 14.83B | |
| +0.14% | +0.46% | +27.20% | +183.34% | 14.06B | |
| Average | -0.62% | -2.36% | +33.93% | +154.31% | 23.36B | |
| Weighted average by Cap. | -1.44% | -2.36% | +41.89% | +137.73% |
| 2020 | 2021 | |
|---|---|---|
| Net sales | 3.57M 3.12M 2.88M 2.65M 5M 344M 5.11M 34.41M 13.53M 168M 13.41M 13.11M 580M | 1.56M 1.37M 1.26M 1.16M 2.19M 151M 2.24M 15.07M 5.93M 73.72M 5.87M 5.74M 254M |
| Net income | -1.21M -1.06M -974K -898K -1.69M -116M -1.73M -11.64M -4.58M -56.97M -4.54M -4.44M -196M | -879K -768K -709K -653K -1.23M -84.65M -1.26M -8.47M -3.33M -41.46M -3.3M -3.23M -143M |
| Net Debt | 5.86M 5.12M 4.72M 4.35M 8.2M 564M 8.39M 56.44M 22.2M 276M 21.99M 21.51M 951M | 135K 118K 109K 100K 189K 13M 193K 1.3M 512K 6.37M 507K 496K 21.92M |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-15 | US$0.000100 | 0.00% | 6,000 |
| 26-07-13 | US$0.000100 | -50.00% | 376 |
- Stock Market
- Stocks
- ACUR Stock
Select your edition
All financial news and data tailored to specific country editions
